exenatide synthetic

exenatide synthetic (BYETTA) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: subcutaneous. Current US regulatory status: approved.

BYETTA is a marketed brand name for exenatide synthetic. Check FDA Drugs@FDA for the current US label holder and prescribing information.

exenatide synthetic has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.